In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 29th, 2005 | 36 | No |
Popular Name: 3-[4-[1,3-bis(cyclohexylmethyl)-2,6-dioxo-7H-purin-8-yl]phenyl]prop-2-enoic 3-[4-[1,3-bis(cyclohexylmethyl)-…
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 6.66 | -0.58 | -51.63 | 1 | 8 | -1 | 112 | 489.596 | 7 | ↓ |
Mid Mid (pH 6-8) | 6.66 | -0.25 | -74.24 | 2 | 8 | 0 | 114 | 490.604 | 7 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
PUBCHEM_PATENT_ID | EP0970081A1; WO1996004280A1; WO1998035966A1 | IBM Patent Data |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AA1R-1-E | Adenosine A1 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4890 | 0.21 | Functional ≤ 10μM |
AA2AR-1-E | Adenosine A2a Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 10 | 0.31 | Functional ≤ 10μM |
AA2BR-1-E | Adenosine A2b Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 199 | 0.26 | Functional ≤ 10μM |
AA3R-1-E | Adenosine A3 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 922 | 0.23 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AA1R_RAT | P25099 | Adenosine A1 Receptor, Rat | 602 | 0.24 | Functional ≤ 10μM |
AA1R_HUMAN | P30542 | Adenosine A1 Receptor, Human | 4890 | 0.21 | Functional ≤ 10μM |
AA2AR_RAT | P30543 | Adenosine A2a Receptor, Rat | 10 | 0.31 | Functional ≤ 10μM |
AA2AR_HUMAN | P29274 | Adenosine A2a Receptor, Human | 1518 | 0.23 | Functional ≤ 10μM |
AA2BR_HUMAN | P29275 | Adenosine A2b Receptor, Human | 199 | 0.26 | Functional ≤ 10μM |
AA3R_HUMAN | P33765 | Adenosine A3 Receptor, Human | 922 | 0.23 | Functional ≤ 10μM |
Description | Species |
---|---|
Adenosine P1 receptors | |
G alpha (i) signalling events | |
G alpha (s) signalling events | |
NGF-independant TRKA activation |